Filing Determination and Review PlanningFrom the time a marketing application is submitted, FDA has 60 days to perform an initial review. During this time FDA will determine if the submission is sufficiently complete to perform a more substantive review.
Day 60 post-submission is designated as the filing decision date.Prior to the filing decision date, each review discipline will make a recommendation about the “file-ability” of the application.If the initial review uncovers deficiencies, FDA may alert the sponsor at any time using information requests and/or may note the deficiencies as part of the filing letter.
Refuse to file designations are made by Day 60 post filing.
If the 60 day is a calendar 60 days, it’s getting close to crunch time..
trial time, page-36
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
-0.050(4.39%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.17 | $1.07 | $8.385M | 7.489M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8500 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 26954 | 3 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |